Education
About Us
Working with TipRanks
Follow Us
Qiagen NV (CH:QGEN)
:QGEN
Earnings Data
Report Date
Feb 10, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.49Last Year’s EPS
0.49Same Quarter Last Year
Moderate Buy
Based on 12 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
QIAGEN demonstrated strong and consistent performance, with significant achievements in strategic initiatives, financial growth, and product segment performance. Despite challenges such as the U.S. government shutdown, headwinds from currency and tariffs, and regional sales declines, the company's positive trajectory and future growth plans contribute to an overall positive sentiment.Company Guidance
Consistent Performance and Strategic Initiatives
QIAGEN delivered its 24th consecutive quarter meeting or exceeding targets, with a focus on high-growth areas of molecular research and testing. Key strategic initiatives include the acquisition of Parse Biosciences and a $500 million synthetic share repurchase.
Financial Metrics and Growth
Net sales rose 6% to $533 million, with core sales increasing 6% CER. Adjusted diluted EPS was $0.61, above the outlook of $0.58. The company raised its EPS target for 2025 by $0.10, reflecting strong performance.
Strong Product Segment Performance
QIAstat diagnostics and QuantiFERON both grew by 11% CER, while Sample technologies returned to growth with sales rising 3% CER. Digital PCR platform QIAcuity maintained double-digit CER growth.
Positive Cash Flow and Shareholder Returns
Operating cash flow was $466 million for the first nine months of 2025. A $500 million share repurchase is set for completion in January 2026, contributing to a total shareholder return goal of $1 billion by 2028.
Future Growth and Strategic Planning
QIAGEN is on track to achieve a 7% sales CAGR from 2024 to 2028, with ambitions to move well above a 31% adjusted operating income target by 2028.
CH:QGEN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CH:QGEN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 04, 2025 | CHF50.36 | ― | ― |
Aug 05, 2025 | CHF50.36 | CHF50.36 | 0.00% |
May 07, 2025 | CHF50.36 | CHF50.36 | 0.00% |
Feb 05, 2025 | CHF50.36 | CHF50.36 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Qiagen NV (CH:QGEN) report earnings?
Qiagen NV (CH:QGEN) is schdueled to report earning on Feb 10, 2026, After Close (Confirmed).
What is Qiagen NV (CH:QGEN) earnings time?
Qiagen NV (CH:QGEN) earnings time is at Feb 10, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Qiagen NV stock?
The P/E ratio of Qiagen is N/A.
What is CH:QGEN EPS forecast?
CH:QGEN EPS forecast for the fiscal quarter 2025 (Q4) is 0.49.